Though Biosimilar business is considered as one of the most strategic and future business worldwide, yet the development of the regulations , submission requirements and pathways is not yet established in all MENA countries. The scope of this training under the patronage of the Morocco ministry of health will cover the international guidelines e.g EMA and USFDA in addition to MENA authorities experience highlighting the major risks of registering intended copies.

I have attached the detailed agenda for your reference, also please find enclosed below the link for additional details related to the avenue and registration process. 

http://menabiosimilars.com/conference-details/